Experts differ on the strength of the evidence.
A tweet from France’s health minister has stirred up questions about whether people with COVID-19 should take ibuprofen.
On Saturday, the health minister, Olivier Véran, tweeted (in French) that “taking anti-inflammatory drugs (ibuprofen, cortisone . . .) could be an aggravating factor for the infection. If you have a fever, take paracetamol.” Paracetamol is the same drug as acetaminophen.
CNN updated a story at 6:24 a.m. today that quoted several infectious disease experts as saying that there was no evidence or little firm evidence that ibuprofen worsens COVID-19.
Ibuprofen and other nonsteroidal anti-inflammatory drugs would be taken to treat the sympotms of a COVID-19 infection, not as anti-virals. Acetaminophen, which is not an NSAID, would be taken for the same reason.
BMJ, the leading medical journal in Britain that posts news items as well as peer-reviewed articles, posted a news item today that says the Véran tweet may have been prompted in part by remarks attributed to an infectious diseases doctor in southwest France. She was reported to have cited four cases of young patients with COVID-19 and no underlying health problems who went on to develop serious symptoms after using nonsteroidal anti-inflammatory drugs (NSAIDs) in the early stage of their symptoms, according to BMJ.
And the CNN report noted that “Veran’s advice is in line with some countries’ general guidance on anti-inflammatory painkillers such as ibuprofen, even if their specific connection to the coronavirus is not clear.”
BMJ quoted Ian Jones, a professor of virology at the University of Reading, as sayig that ibuprofen’s anti-inflammatory properties could “dampen down” the immune system, which could slow the recovery process.
“For COVID-19, research is needed into the effects of specific NSAIDs among people with different underlying health conditions. In the meantime, for treating symptoms such as fever and sore throat, it seems sensible to stick to paracetamol as first choice,” Charlotte Warren-Gash, associate professor of epidemiology at the London School of Hygiene and Tropical Medicine, told BMJ.
Personal Health Information was Released in Change Healthcare Hack
April 23rd 2024UnitedHealth has found 22 screenshots, allegedly from Change Healthcare files, that were posted for about a week on the dark web. Some of these contained personal health information. The extent of data release is not yet known.
Read More
Drug Discount Programs Poised to Change with New Tech, Pharma Execs Survey Finds
April 22nd 2024It is somewhat mind-boggling in 2024 that more than one-third of pharma organizations still rely on manual entry of data into Excel spreadsheets to track duplicate discounts that can cost millions of dollars a year in lost revenue
Read More
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen